Regulation - Victoza, Financial

Filter

Current filters:

VictozaFinancial

Popular Filters

Zealand Pharma valuation hinged on Lyxi/Lanti "fixflex"

23-11-2012

The recent European Medicine Agency advisory committee, CHMP, positive opinion for French drug major…

BiotechnologyDiabetesFinancialLantusLyxumiaNovo NordiskRegulationResearchSanofiTresibaVictozaZealand Pharma

AstraZeneca to investment $200 million in Chinese manufacturing plant; Novo Nordisk debuts Victoza

10-10-2011

Anglo-Swedish drug major AstraZeneca ILSE: AZN) said this morning that it is investing $200 million in…

Asia-PacificAstraZenecaDiabetesFinancialMarkets & MarketingNovo NordiskPharmaceuticalRegulationVictoza

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top